Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study
International Archives of Allergy and Immunology · 2025
DOI: 10.1159/000542589 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2025. Verfasst von Melinda Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Penicillins, Drug Hypersensitivity, Deep Learning, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Erroneous penicillin allergy labels are associated with significant health and economic costs. This study aimed to determine whether deep learning-facilitated proactive consultation to facilitate delabelling may further enhance inpatient penicillin allergy delabelling.
Methods
This prospective implementation study utilised a deep learning-guided proactive consultation service, which utilised an inpatient penicillin allergy delabelling protocol. The intervention group comprised all admitted inpatients with a penicillin allergy over the course of a 14-week period in a tertiary hospital. The rate of penicillin allergy delabelling in the intervention group was compared to that of a historical control group.
Results
There were 439 patients included in the study, of whom 121 were identified by the algorithm as suitable for penicillin allergy interrogation. Of those identified by the algorithm, 16.5% were successfully delabelled in the inpatient setting within the same admission and 9.9% were referred for outpatient testing. This result was statistically significantly greater compared to the rate of delabelling in the historical control group (0%, p = 0.00001). There were no adverse reactions. The projected annual savings associated with the program over a 12-month period were AUD 1,170,617.16.
Conclusion
Deep learning-facilitated proactive inpatient penicillin allergy delabelling was effective, safe, and economical in this single-centre implementation study. Further studies should seek to examine this approach in diverse centres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- University of Adelaide, Adelaide, South Australia, Australia.
- Ballarat Base Hospital, Ballarat, Victoria, Australia.
- Flinders University, Adelaide, South Australia, Australia.
- Flinders University, Adelaide, South Australia, Australia, stephenbacchi@gmail.com.
- Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia, stephenbacchi@gmail.com.
Zitieren
APA
Jiang, M., Stretton, B., Kovoor, J., Inglis, J. M., Thompkins, S., Yuson, C., Shakib, S., Smith, W. B., & Bacchi, S. (2025). Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study. International Archives of Allergy and Immunology. https://doi.org/10.1159/000542589
Vancouver
Jiang M, Stretton B, Kovoor J, Inglis JM, Thompkins S, Yuson C, et al. Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study. International Archives of Allergy and Immunology. 2025. doi:10.1159/000542589
BibTeX
@article{Jiang2025,
author = {Jiang, Melinda and Stretton, Brandon and Kovoor, Joshua and Inglis, Joshua M and Thompkins, Sophia and Yuson, Carlo and Shakib, Sepehr and Smith, William B and Bacchi, Stephen},
title = {Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study},
journal = {International Archives of Allergy and Immunology},
year = {2025},
doi = {10.1159/000542589}
}
EUVIMED